CN101437491B - 用于免疫疗法的纳米颗粒 - Google Patents
用于免疫疗法的纳米颗粒 Download PDFInfo
- Publication number
- CN101437491B CN101437491B CN2007800143677A CN200780014367A CN101437491B CN 101437491 B CN101437491 B CN 101437491B CN 2007800143677 A CN2007800143677 A CN 2007800143677A CN 200780014367 A CN200780014367 A CN 200780014367A CN 101437491 B CN101437491 B CN 101437491B
- Authority
- CN
- China
- Prior art keywords
- nano
- particle
- granule
- antigen
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77513206P | 2006-02-21 | 2006-02-21 | |
US60/775,132 | 2006-02-21 | ||
US11/707,627 US8021689B2 (en) | 2006-02-21 | 2007-02-19 | Nanoparticles for immunotherapy |
US11/707,627 | 2007-02-19 | ||
PCT/US2007/004671 WO2007098254A2 (fr) | 2006-02-21 | 2007-02-21 | Nanoparticules pour immunothérapie |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101437491A CN101437491A (zh) | 2009-05-20 |
CN101437491B true CN101437491B (zh) | 2013-01-02 |
Family
ID=38438002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007800143677A Active CN101437491B (zh) | 2006-02-21 | 2007-02-21 | 用于免疫疗法的纳米颗粒 |
Country Status (8)
Country | Link |
---|---|
US (1) | US8021689B2 (fr) |
EP (1) | EP1993511B1 (fr) |
JP (1) | JP5506196B2 (fr) |
CN (1) | CN101437491B (fr) |
AU (1) | AU2007217514B2 (fr) |
CA (1) | CA2661700C (fr) |
ES (1) | ES2709391T3 (fr) |
WO (1) | WO2007098254A2 (fr) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPR011700A0 (en) * | 2000-09-14 | 2000-10-05 | Austin Research Institute, The | Composition comprising immunogenic virus sized particles (VSP) |
US9492400B2 (en) * | 2004-11-04 | 2016-11-15 | Massachusetts Institute Of Technology | Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals |
US9267937B2 (en) | 2005-12-15 | 2016-02-23 | Massachusetts Institute Of Technology | System for screening particles |
ES2776100T3 (es) * | 2006-03-31 | 2020-07-29 | Massachusetts Inst Technology | Sistema para el suministro dirigido de agentes terapéuticos |
CA2652280C (fr) | 2006-05-15 | 2014-01-28 | Massachusetts Institute Of Technology | Polymeres pour particules fonctionnelles |
US20110052697A1 (en) * | 2006-05-17 | 2011-03-03 | Gwangju Institute Of Science & Technology | Aptamer-Directed Drug Delivery |
US9381477B2 (en) * | 2006-06-23 | 2016-07-05 | Massachusetts Institute Of Technology | Microfluidic synthesis of organic nanoparticles |
US20100144845A1 (en) * | 2006-08-04 | 2010-06-10 | Massachusetts Institute Of Technology | Oligonucleotide systems for targeted intracellular delivery |
US20100303723A1 (en) * | 2006-11-20 | 2010-12-02 | Massachusetts Institute Of Technology | Drug delivery systems using fc fragments |
US9217129B2 (en) | 2007-02-09 | 2015-12-22 | Massachusetts Institute Of Technology | Oscillating cell culture bioreactor |
WO2008124632A1 (fr) * | 2007-04-04 | 2008-10-16 | Massachusetts Institute Of Technology | Nanoparticules assistées par des composés amphiphiles pour délivrance ciblée |
AU2008314647B2 (en) * | 2007-10-12 | 2013-03-21 | Massachusetts Institute Of Technology | Vaccine nanotechnology |
US8323696B2 (en) * | 2008-08-29 | 2012-12-04 | Ecole Polytechnique Federale De Lausanne | Nanoparticles for immunotherapy |
US8343497B2 (en) | 2008-10-12 | 2013-01-01 | The Brigham And Women's Hospital, Inc. | Targeting of antigen presenting cells with immunonanotherapeutics |
US8591905B2 (en) | 2008-10-12 | 2013-11-26 | The Brigham And Women's Hospital, Inc. | Nicotine immunonanotherapeutics |
US8277812B2 (en) | 2008-10-12 | 2012-10-02 | Massachusetts Institute Of Technology | Immunonanotherapeutics that provide IgG humoral response without T-cell antigen |
US8343498B2 (en) * | 2008-10-12 | 2013-01-01 | Massachusetts Institute Of Technology | Adjuvant incorporation in immunonanotherapeutics |
WO2010068432A1 (fr) * | 2008-11-25 | 2010-06-17 | Ecole Polytechnique Federale De Lausanne (Epfl) | Copolymères en bloc et leurs utilisations |
KR20120022984A (ko) * | 2009-04-21 | 2012-03-12 | 셀렉타 바이오사이언시즈, 인크. | Th1 편향 반응을 제공하는 면역나노치료법 |
JP6297776B2 (ja) | 2009-05-27 | 2018-03-20 | セレクタ バイオサイエンシーズ インコーポレーテッドSelecta Biosciences,Inc. | 免疫調節薬−高分子化合物 |
EP2575876B1 (fr) | 2010-05-26 | 2017-12-06 | Selecta Biosciences, Inc. | Vaccins polyvalents à nanovéhicules synthétiques |
US9850296B2 (en) | 2010-08-10 | 2017-12-26 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
US9517257B2 (en) | 2010-08-10 | 2016-12-13 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
JP6017422B2 (ja) | 2010-08-10 | 2016-11-02 | エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ(ウペエフエル)Ecole Polytechnique Federale de Lausanne (EPFL) | 赤血球結合療法 |
DE102010040565A1 (de) | 2010-09-10 | 2012-03-15 | Robert Bosch Gmbh | Verfahren zum Einstellen der von einer Feststellbremse ausgeübten Klemmkraft |
WO2012061717A1 (fr) | 2010-11-05 | 2012-05-10 | Selecta Biosciences, Inc. | Composés nicotiniques modifiés et procédés associés |
KR102112002B1 (ko) * | 2011-04-29 | 2020-05-18 | 셀렉타 바이오사이언시즈, 인크. | 치료적 단백질에 대해 면역 반응을 감소시키는 관용원성 합성 나노운반체 |
MX2014001142A (es) * | 2011-07-29 | 2014-02-27 | Selecta Biosciences Inc | Nanoportadores sinteticos que generan respuestas inmunitarias humorales y de linfocitos t citotoxicos (ctl). |
SG11201404943PA (en) | 2012-02-15 | 2014-10-30 | Ecole Polytech | Erythrocyte-binding therapeutics |
WO2013163176A1 (fr) | 2012-04-23 | 2013-10-31 | Allertein Therapeutics, Llc | Nanoparticules pour le traitement d'allergies |
US9879062B2 (en) | 2012-07-03 | 2018-01-30 | Ecole Polytechnique Federale De Lausanne | Protein-binding peptide isolated from placenta growth factor |
US9540428B2 (en) | 2012-07-03 | 2017-01-10 | Ecole Polytechnique Federale De Lausanne (Epfl) | Extracellular matrix heparin-binding domains |
AU2014248090B2 (en) | 2013-04-03 | 2018-08-02 | N-Fold Llc | Novel nanoparticle compositions |
CN105339012A (zh) * | 2013-05-03 | 2016-02-17 | 西莱克塔生物科技公司 | 降低i型和iv型超敏反应的致耐受性合成纳米载体的局部伴随施用 |
WO2015013510A1 (fr) | 2013-07-25 | 2015-01-29 | Ecole Polytechnique Federale De Lausanne Epfl | Matériaux en nanofibrilles à rapport d'aspect élevé |
KR101916288B1 (ko) | 2014-01-06 | 2018-11-07 | 나노코 테크놀로지스 리미티드 | 표면 변형된 나노입자 |
US10046056B2 (en) | 2014-02-21 | 2018-08-14 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
US10946079B2 (en) | 2014-02-21 | 2021-03-16 | Ecole Polytechnique Federale De Lausanne | Glycotargeting therapeutics |
AU2015233084B2 (en) | 2014-02-21 | 2020-12-17 | Anokion Sa | Glycotargeting therapeutics |
US10953101B2 (en) | 2014-02-21 | 2021-03-23 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
US20150359865A1 (en) * | 2014-06-17 | 2015-12-17 | Selecta Biosciences, Inc. | Tolerogenic synthetic nanocarriers for t-cell-mediated autoimmune disease |
CA2957800A1 (fr) | 2014-09-07 | 2016-03-10 | Selecta Biosciences, Inc. | Procedes et compositions permettant d'attenuer les reponses immunitaires au vecteur de transfert anti-virales |
WO2018169811A1 (fr) | 2017-03-11 | 2018-09-20 | Selecta Biosciences, Inc. | Procédés et compositions associés à un traitement combiné avec anti-inflammatoires et nanovecteurs synthétiques comprenant un immunosuppresseur |
US20180280488A1 (en) * | 2017-03-31 | 2018-10-04 | University of Alaska Anchorage | Methods and Compositions for Binding Complement C3 for Targeting of Immune Cells |
WO2018232176A1 (fr) | 2017-06-16 | 2018-12-20 | The University Of Chicago | Compositions et procédés d'induction d'une tolérance immunitaire |
EP3710466A2 (fr) | 2017-11-13 | 2020-09-23 | The University of Chicago | Méthodes et compositions pour le traitement des plaies |
CN114053433A (zh) * | 2021-10-20 | 2022-02-18 | 北京中医药大学东方医院 | 刺激响应型纳米材料及其在制备原位肿瘤疫苗中的用途 |
CN114259463B (zh) * | 2022-02-11 | 2023-03-28 | 山东大学 | 一种靶向补体蛋白发挥抗炎作用的PF-HA-diSE水凝胶及其制备方法与应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6333051B1 (en) * | 1998-09-03 | 2001-12-25 | Supratek Pharma, Inc. | Nanogel networks and biological agent compositions thereof |
US20040247624A1 (en) * | 2003-06-05 | 2004-12-09 | Unger Evan Charles | Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0712421A1 (fr) * | 1993-07-23 | 1996-05-22 | Massachusetts Institute Of Technology | Nanoparticules et microparticules de copolymeres multibloc hydrophiles-hydrophobes non lineaires |
US5565215A (en) * | 1993-07-23 | 1996-10-15 | Massachusettes Institute Of Technology | Biodegradable injectable particles for imaging |
GB9406094D0 (en) * | 1994-03-28 | 1994-05-18 | Univ Nottingham And University | Polymer microspheres and a method of production thereof |
JP2000510449A (ja) | 1996-04-10 | 2000-08-15 | 南カリフォルニア大学 | 増殖性硝子体網膜症に対する遺伝子治療 |
US6083725A (en) | 1996-09-13 | 2000-07-04 | Transkaryotic Therapies, Inc. | Tranfected human cells expressing human α-galactosidase A protein |
US7157089B1 (en) | 1996-11-26 | 2007-01-02 | Stressgen Biotechnologies Corporation | Immune responses using compositions containing stress proteins |
GB9718129D0 (en) | 1997-08-27 | 1997-10-29 | Isis Innovation | Branched structures |
TWI221854B (en) | 2000-05-26 | 2004-10-11 | Anawrahta Biotech Co Ltd | Lac shuttle vectors, kit for expression of a heterologous gene and DNA vaccine carrier containing the same |
US6998115B2 (en) | 2000-10-10 | 2006-02-14 | Massachusetts Institute Of Technology | Biodegradable poly(β-amino esters) and uses thereof |
WO2002061049A2 (fr) | 2001-01-31 | 2002-08-08 | Millennium Pharmaceuticals, Inc. | Nouvelles molecules de la famille des proteines pyrin/nbs/lrr et leurs utilisations |
WO2002067908A1 (fr) | 2001-02-26 | 2002-09-06 | Duke University | Nouveaux dendrimeres et leurs utilisations biomedicales |
US20040126900A1 (en) * | 2001-04-13 | 2004-07-01 | Barry Stephen E | High affinity peptide- containing nanoparticles |
US7052694B2 (en) | 2002-07-16 | 2006-05-30 | Mayo Foundation For Medical Education And Research | Dendritic cell potentiation |
US7846201B2 (en) * | 2004-02-20 | 2010-12-07 | The Children's Hospital Of Philadelphia | Magnetically-driven biodegradable gene delivery nanoparticles formulated with surface-attached polycationic complex |
US7316816B2 (en) * | 2004-06-10 | 2008-01-08 | Agency For Science Technology And Research | Temperature and pH sensitive copolymers |
US20060204443A1 (en) | 2005-03-11 | 2006-09-14 | The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services | Methods for tumor treatment using dendrimer conjugates |
-
2007
- 2007-02-19 US US11/707,627 patent/US8021689B2/en active Active
- 2007-02-21 AU AU2007217514A patent/AU2007217514B2/en active Active
- 2007-02-21 CA CA2661700A patent/CA2661700C/fr active Active
- 2007-02-21 ES ES07751436T patent/ES2709391T3/es active Active
- 2007-02-21 CN CN2007800143677A patent/CN101437491B/zh active Active
- 2007-02-21 WO PCT/US2007/004671 patent/WO2007098254A2/fr active Application Filing
- 2007-02-21 EP EP07751436.2A patent/EP1993511B1/fr active Active
- 2007-02-21 JP JP2008556431A patent/JP5506196B2/ja active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6333051B1 (en) * | 1998-09-03 | 2001-12-25 | Supratek Pharma, Inc. | Nanogel networks and biological agent compositions thereof |
US20040247624A1 (en) * | 2003-06-05 | 2004-12-09 | Unger Evan Charles | Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility |
Also Published As
Publication number | Publication date |
---|---|
CN101437491A (zh) | 2009-05-20 |
AU2007217514B2 (en) | 2013-02-21 |
WO2007098254A2 (fr) | 2007-08-30 |
EP1993511B1 (fr) | 2018-10-31 |
JP5506196B2 (ja) | 2014-05-28 |
EP1993511A4 (fr) | 2014-11-05 |
WO2007098254A3 (fr) | 2008-09-25 |
JP2009527566A (ja) | 2009-07-30 |
US20080031899A1 (en) | 2008-02-07 |
AU2007217514A1 (en) | 2007-08-30 |
EP1993511A2 (fr) | 2008-11-26 |
US8021689B2 (en) | 2011-09-20 |
CA2661700C (fr) | 2020-07-07 |
CA2661700A1 (fr) | 2007-08-30 |
ES2709391T3 (es) | 2019-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101437491B (zh) | 用于免疫疗法的纳米颗粒 | |
CN102202653B (zh) | 用于免疫疗法的纳米颗粒 | |
US20230338576A1 (en) | Covalent polymer-antigen conjugated particles | |
Reddy et al. | In vivo targeting of dendritic cells in lymph nodes with poly (propylene sulfide) nanoparticles | |
Yao et al. | Preventative vaccine-loaded mannosylated chitosan nanoparticles intended for nasal mucosal delivery enhance immune responses and potent tumor immunity | |
Bershteyn et al. | Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine | |
Cohen et al. | T-cell activation by antigen-loaded pH-sensitive hydrogel particles in vivo: the effect of particle size | |
JP2016528254A (ja) | ペプチドコンジュゲート粒子 | |
Kapadia et al. | Reduction sensitive PEG hydrogels for codelivery of antigen and adjuvant to induce potent CTLs | |
Chittasupho et al. | Nanoparticles targeting dendritic cell surface molecules effectively block T cell conjugation and shift response | |
Shin et al. | Development of a cancer nanovaccine to induce antigen-specific immune responses based on large-sized Porous silica nanoparticles | |
Kim et al. | Induction of peptide-specific CTL activity and inhibition of tumor growth following immunization with nanoparticles coated with tumor peptide-MHC-I complexes | |
Shimizu et al. | Development of an antigen delivery system for a B cell-targeted vaccine as an alternative to dendritic cell-targeted vaccines | |
Hwang et al. | DNA Anchoring Strength Directly Correlates with Spherical Nucleic Acid–Based HPV E7 Cancer Vaccine Potency | |
Akagi et al. | Functional Nanoparticles for Vaccine Delivery Systems | |
Ruff | Particle-based vaccination through direct targeting of antigen presenting cells | |
Walters et al. | i AHVLA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1131551 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1131551 Country of ref document: HK |